A Certified Reference Material of deoxycholic acid
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Deoxycholic Acid (CRM)

Item No. 44906

Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
(3α,5β,12α)-, 3,12-dihydroxy-cholan-24-oic acid
CAS Number
83-44-3
Synonyms
  • Cholanoic acid
  • DCA
  • NSC 8797
Molecular Formula
C24H40O4
Formula Weight
392.6
Formulation (Request formulation change)
A 1 mg/ml solution in methanol
SMILES
O[C@@H]1CC[C@@]2(C)[C@@](CC[C@]3([H])[C@]2([H])C[C@H](O)[C@@]4(C)[C@@]3([H])CC[C@]4([H])[C@H](C)CCC(O)=O)([H])C1
InChi Code
InChI=1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1
InChi Key
KXGVEGMKQFWNSR-LLQZFEROSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $79

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Deoxycholic acid (CRM) (Item No. 44906) is a certified reference material categorized as a secondary bile acid.1 Serum levels of deoxycholic acid are increased in men, but not women, with colorectal cancer.2 In contrast, decreased plasma levels of deoxycholic acid are associated with an increase in adverse cardiac events in patients with acute pulmonary embolism.3 This product is intended for use in quantitative analytical research applications. This product is also available as two general research tools (Item Nos. 20756 | 18231).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Thanissery, R., Winston, J.A., and Theriot, C.M. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. Anaerobe 45, 86-100 (2017).

    2. Bayerdörffer, E., Mannes, G.A., Richter, W.O., et al. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 104(1), 145-151 (1993).

    3. Sun, N., Chen, Y.-Q., Chen, Y.-S., et al. Plasma deoxycholic acid levels are associated with hemodynamic and clinical outcomes in acute pulmonary embolism patients. Cardiovasc. Toxicol. 24(9), 879-888 (2024).